icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
June 23-26 2021
Back grey_arrow_rt.gif
 
 
 
Risk of multiple drug-drug interactions (DDIs) in
HCV patients receiving pangenotypic DAAs (pDAAs):
A complex drug interaction scenario first time
evaluated in German patients

 
 
  EASL International Liver Congress, June 23-26, 2021
 
F. Tacke1, G. Niess2, M. GŁndogdu2, A. Hintz3, T. Umland3
 
1Charite - Universitatsmedizin Berlin, Department of Hepatology and Gastroenterology, Berlin, Germany, 2Gilead Sciences GmbH, Martinsried / Munich, Germany; 3Alexander Apotheke, Hamburg, Germany

0626211

0626212

0626213

0626214

0626215

0626216copy

0626217

0626218

0626219

06262110

06262111